LICART - International Biopharmaceutical Industry

Current Edition

Volume 4 Issue 4

5 Drugs Facing Key Patent Expirations and Potential Generic Entry from December 2021 – February 2022

A challenge in anticipating generic entry is elucidating which patents and regulatory protections constrain generic entry. Yali Friedman at DrugPatentWatch, presents ...

9 December 2021 Volume 4 Issue 4 aspirin | FDA

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

5 Drugs Facing Key Patent Expirations and Potential Generic Entry from December 2021 – February 2022

International Biopharmaceutical Industry